GlaxoSmithKline (GSK) stock forecast for 2026. Forecast tables and graphs.

GlaxoSmithKline (GSK) stock forecast for 2026

The forecast has been updated: June 16, 2021 14:08


GlaxoSmithKline stock price online today

Analyst Target Price

47.77

Dividend Date

08.07.2021

Ex Dividend Date

20.05.2021

Last Split Factor

2:1

Last Split Date

12.11.1991

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $47.77 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (37.1016 $).

50 Day Moving Average is the resistance level (38.628 $).




GSK Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 38.95 38.11 39.84 4.35 %
Feb 39.21 38.10 39.92 4.56 %
Mar 39.19 38.72 39.80 2.73 %
Apr 38.64 38.14 39.32 2.99 %
May 39.65 38.77 40.75 4.86 %
Jun 41.03 39.84 42.31 5.82 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 Great West Road, Brentford, United Kingdom, TW8 9GS

Market Capitalization

102 063 972 352 $

EBITDA

9 715 999 744

PE Ratio

13.7899

PEG Ratio

4.7183

Dividend Per Share

0.8

Dividend Yield

0.0198

EPS

2.942

Quarterly Earnings Growth YOY

-0.317

Quarterly Revenue Growth YOY

-0.184

Trailing PE

13.7899

Forward PE

14.5349

EV To Revenue

3.9892

EV To EBITDA

12.9396

52 Week High

40.58

52 Week Low

31.82

50 Day Moving Average

38.628

200 Day Moving Average

37.1016

Shares Outstanding

2515749888

Shares Float

2445716550

Shares Short Prior Month

24921522

Short Ratio

5.36

Percent Insiders

0.013

Percent Institutions

12.579

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 38.95. Positive monthly dynamics of the instrument is expected with 4.346% volatility is expected.

Pessimistic forecast: 38.11

Optimistic: 39.84


GlaxoSmithKline stock forecast for Feb 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 39.21. Positive monthly dynamics of the instrument is expected with 4.558% volatility is expected.

Pessimistic forecast: 38.10

Optimistic: 39.92


GlaxoSmithKline stock forecast for Mar 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 39.19. Negative monthly dynamics of the instrument is expected with 2.727% volatility is expected.

Pessimistic forecast: 38.72

Optimistic: 39.80


GlaxoSmithKline stock forecast for Apr 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 38.64. Negative monthly dynamics of the instrument is expected with 2.989% volatility is expected.

Pessimistic forecast: 38.14

Optimistic: 39.32


GlaxoSmithKline stock forecast for May 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 39.65. Positive monthly dynamics of the instrument is expected with 4.857% volatility is expected.

Pessimistic forecast: 38.77

Optimistic: 40.75


GlaxoSmithKline stock forecast for Jun 2026.
Estimated Average Forecasted GlaxoSmithKline Price: 41.03. Positive monthly dynamics of the instrument is expected with 5.824% volatility is expected.

Pessimistic forecast: 39.84

Optimistic: 42.31



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 111.63 (17.06.2021) 1.43 %
AbbVie Inc.
ABBV 113.12 (18.06.2021) -1.55 %
Aeterna Zentaris Inc.
AEZS 0.9049 (17.06.2021) -4.09 %
Allakos Inc.
ALLK 89.38 (17.06.2021) 0.13 %
Allogene Therapeutics, Inc.
ALLO 24.69 (17.06.2021) -2.33 %
Amgen Inc.
AMGN 240.76 (17.06.2021) 0.49 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.36 (17.06.2021) 0.00 %
Aurora Cannabis Inc.
ACB 9.04 (17.06.2021) -2.38 %
Becton Dickinson and Company
BDX 240.25 (17.06.2021) -0.01 %
Biogen Inc.
BIIB 388.44 (18.06.2021) 1.28 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 94.27 (17.06.2021) 1.39 %
BioNTech SE
BNTX 212.42 (18.06.2021) -0.83 %
bluebird bio, Inc.
BLUE 32.98 (17.06.2021) 0.61 %
Boston Scientific Corp.
BSX 43.35 (17.06.2021) 1.33 %
Bristol-Myers Squibb Company
BMY 66.47 (18.06.2021) -0.45 %
Canopy Growth Corp.
CGC 23.91 (17.06.2021) -0.87 %
Castle Biosciences, Inc.
CSTL 76.1 (17.06.2021) 5.50 %
Eli Lilly and Company
LLY 222.21 (17.06.2021) 0.66 %
Emergent BioSolutions Inc.
EBS 63.12 (17.06.2021) 1.87 %
Exelixis, Inc.
EXEL 22.41 (18.06.2021) 1.27 %
G1 Therapeutics, Inc.
GTHX 21.97 (17.06.2021) 1.10 %
Gilead Sciences, Inc.
GILD 67.22 (17.06.2021) -0.16 %
GlaxoSmithKline plc
GSK 40.57 (17.06.2021) -0.22 %
GoodRx Holdings, Inc.
GDRX 37.89 (17.06.2021) 2.02 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 83.96 (18.06.2021) 1.00 %
Inovio Pharmaceuticals, Inc.
INO 8.49 (18.06.2021) -3.74 %
Johnson & Johnson
JNJ 161.98 (18.06.2021) -1.96 %
Medtronic plc.
MDT 125.21 (17.06.2021) 0.15 %
Merck & Co., Inc.
MRK 76.61 (18.06.2021) -0.80 %
Moderna, Inc.
MRNA 202.47 (17.06.2021) 2.34 %
Novartis AG
NVS 94.15 (17.06.2021) 0.38 %
Novavax, Inc.
NVAX 179.89 (17.06.2021) 2.07 %
ObsEva SA
OBSV 2.97 (17.06.2021) -0.67 %
OrganiGram Holdings Inc.
OGI 2.91 (18.06.2021) -4.28 %
Pfizer Inc.
PFE 39.48 (17.06.2021) 0.46 %
Regeneron Pharmaceuticals, Inc.
REGN 537.92 (18.06.2021) 0.36 %
Sanofi
SNY 53.24 (17.06.2021) -0.34 %
Schrodinger, Inc.
SDGR 76.08 (17.06.2021) 2.13 %
Senseonics Holdings, Inc.
SENS 3.62 (17.06.2021) -1.09 %
Sorrento Therapeutics, Inc.
SRNE 8.67 (17.06.2021) -0.34 %
Stryker Corp.
SYK 259.55 (17.06.2021) 1.23 %
Sundial Growers Inc.
SNDL 0.923 (18.06.2021) -3.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10.4 (17.06.2021) -1.61 %
Thermo Fisher Scientific Inc.
TMO 486.08 (17.06.2021) 3.77 %
Tilray, Inc.
TLRY 16.91 (18.06.2021) -3.21 %
UnitedHealth Group, Inc.
UNH 397.35 (17.06.2021) 0.03 %
Veeva Systems Inc.
VEEV 306.7 (18.06.2021) 0.44 %
Zomedica Corp.
ZOM 0.9035 (17.06.2021) 0.74 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.47 (18.06.2021) -1.97 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.